Non-intoxicating Cannabinoids

About eXoZymes

eXoZymes is redefining complex molecule discovery and manufacturing by combining AI-driven enzyme design with cell-free bioprocessing. The company's platform accelerates evolution, designing stable enzymes in weeks to produce rare or economically inaccessible compounds with high purity and scalability. With a pipeline spanning metabolic health, non-intoxicating cannabinoids, and high-value fragrances, eXoZymes targets capital-light growth across pharmaceutical, wellness, and industrial markets, validated by recent successful pilot-scale runs with partners like Cayman Chemical.

Therapeutic Areas